瑛泰医疗(01501)拟折让约16.13%配股 净筹约8.84亿港元

Core Viewpoint - Ying Tai Medical (01501) announced a placement agreement to issue 35.2 million shares at a price of HKD 26 per share, representing a discount of approximately 16.13% from the closing price of HKD 31.00 on January 14, 2026 [1] Fund Utilization - The net proceeds from the placement are estimated to be approximately HKD 884 million, with 56.54% allocated for investments and potential acquisitions in the medical device industry to expand the product portfolio [1] - Approximately 23.75% of the proceeds will be used to repay existing interest-bearing bank loans [1] - About 19.71% will be allocated for general corporate purposes, including employee costs and daily operational expenses [1]